CTSO

NASDAQ 已收盘

Cytosorbents Corporation

0.38 USD
+0.01+2.53%
盘后 0.38 +1.98%
2026-08-03
市值
$23.70M
市盈率
EPS
-0.19
股息率
52 周区间
0.35 – 1.22
成交量
114.34K
Beta
1.35
目标价
2.88
52W 低 0.3552W 高 1.22
价格走势

公司简介

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery applications, as well as to remove antithrombotic drugs and inflammator...